Dr. Kasher is a known pharmaceutical development change expert with 28 years of experience at Eli Lilly. He is passionate about improving outcomes, bringing patients and research sites into the development process, and dramatically decreasing time to market. His expertise includes novel product development for bench through market launch, research and clinical trial leadership, innovation center start-up as well as new industry paradigm creation. Jeff is currently President of Patients Can’t Wait, a member of the Advisory Boards for Antidote, Be the Partner, BlueCloud, and ZS Associates. He advises several multinational Pharmaceutical companies and CROs, and sits on the DPharm steering committee and faculty.
In 2013 CenterWatch, Jeff was named one of the “20 Innovators Changing the Face of the Clinical Trials Industry.” He received a B.S. in Chemistry from Franklin & Marshall College, a Ph.D. in Pharmacology from the State University of New York, and a Post-Doctoral fellowship in Physiology at Yale University School of Medicine.